Axalbion Therapeutics Limited
13224059
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 24/02/2021
PROFESSOR OF MEDICINE
BRITISH · ENGLAND · Age 75
Also on 1 other board
director · Since 16/03/2021
INVESTMENT DIRECTOR
BRITISH · UNITED KINGDOM · Age 52
Also on 10 other boards
Persons with Significant Control
Mr Jonathan Paul Moulton
British · Guernsey · Age 75
Trafalgar Court, 2nd Floor, East Wing, Guernsey, GY1 3EL
Notified 16/03/2021
Former PSCs
Professor Ashley Arthur Woodcock
Ceased 16/03/2021
Charges0 outstanding
MOULTON GOODIES LIMITED
MOULTON GOODIES LIMITED
CompanyRankvs 110+ SIC 21100 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2023
Net Worth
£3.6M
Balance sheet strength
Cash
£128k
Cash in the bank
Net Current Assets
£157k
Working capital
Current Assets
£226k
Current Liabilities
£69k
Debtors
£98k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 3.27 | +£3.4M |
| 2022 | 2.94 | -£570k |
| 2021 | 3.05 | — |
Derived from filed accounts. Not audited figures.